Clinical Trial Update: Evaluation of EndoRefix Endovascular Delivery System and Staple [NA]

View source ↗

Summary

A clinical trial evaluating the EndoRefix Endovascular Delivery System and Staple for abdominal aortic aneurysm was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Aortic Aneurysm

Drugs mentioned

• EndoRefix Endovascular Delivery System and Staple

Snippet

Sponsor: Lombard Medical | Conditions: AAA Graft Implant for Primary Aneurysm Treatment, AAA Graft Repair to Extend Life of Implant | NA | Status: WITHDRAWN